BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 17259872)

  • 1. Immunogenicity of an inactivated hepatitis A vaccine in infants and young children.
    Bell BP; Negus S; Fiore AE; Plotnik J; Dhotre KB; Williams J; Shapiro CN; McMahon BJ
    Pediatr Infect Dis J; 2007 Feb; 26(2):116-22. PubMed ID: 17259872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis A vaccination of infants: effect of maternal antibody status on antibody persistence and response to a booster dose.
    Fiore AE; Shapiro CN; Sabin K; Labonte K; Darling K; Culver D; Bell BP; Margolis HS
    Pediatr Infect Dis J; 2003 Apr; 22(4):354-9. PubMed ID: 12690277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of maternal antibody on immunogenicity of hepatitis A vaccine in infants.
    Letson GW; Shapiro CN; Kuehn D; Gardea C; Welty TK; Krause DS; Lambert SB; Margolis HS
    J Pediatr; 2004 Mar; 144(3):327-32. PubMed ID: 15001936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis A vaccination of Argentinean infants: comparison of two vaccination schedules.
    López EL; Contrini MM; Xifró MC; Cattaneo MA; Zambrano B; Dumas R; Rouyrre N; Weber F
    Vaccine; 2007 Jan; 25(1):102-8. PubMed ID: 16914234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concomitant administration of a virosome-adjuvanted hepatitis a vaccine with routine childhood vaccines at age twelve to fifteen months: a randomized controlled trial.
    Dagan R; Amir J; Livni G; Greenberg D; Abu-Abed J; Guy L; Ashkenazi S; Foresner G; Tewald F; Schätzl HM; Hoffmann D; Ibanez R; Herzog C
    Pediatr Infect Dis J; 2007 Sep; 26(9):787-93. PubMed ID: 17721372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Persistence of hepatitis A vaccine induced seropositivity in infants and young children by maternal antibody status: 10-year follow-up.
    Sharapov UM; Bulkow LR; Negus SE; Spradling PR; Homan C; Drobeniuc J; Bruce M; Kamili S; Hu DJ; McMahon BJ
    Hepatology; 2012 Aug; 56(2):516-22. PubMed ID: 22371069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity, safety, and interchangeability of two inactivated hepatitis A vaccines in Chilean children.
    Abarca K; Ibánez I; Perret C; Vial P; Zinsou JA
    Int J Infect Dis; 2008 May; 12(3):270-7. PubMed ID: 17988917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody persistence and immune memory in healthy adults following vaccination with a two-dose inactivated hepatitis A vaccine: long-term follow-up at 15 years.
    Van Herck K; Jacquet JM; Van Damme P
    J Med Virol; 2011 Nov; 83(11):1885-91. PubMed ID: 21915861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Immunogenicity of experimentally combined hepatitis A and hepatitis E vaccine at different dosage ratio].
    Dong C; Dai X; Meng JH
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Feb; 23(2):130-3. PubMed ID: 17286906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Safety and immunogenicity of Bilive combined hepatitis A and B vaccine].
    Zhao YL; Chen YG; Li J; Han GX; Tian C; Liang JL; Li G; Wang ZG; Zhu YG; Tian ZN; Zhang HY; Wan ZJ; Liang ZL; Bi SL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Jun; 25(6):470-3. PubMed ID: 15231119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety, tolerability and immunogenicity of VAQTA given concomitantly versus nonconcomitantly with other pediatric vaccines in healthy 12-month-old children.
    Guerra FA; Gress J; Werzberger A; Reisinger K; Walter E; Lakkis H; Grosso AD; Welebob C; Kuter BJ;
    Pediatr Infect Dis J; 2006 Oct; 25(10):912-9. PubMed ID: 17006287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparison of two different vaccination schemes against Hepatitis A and B in Mexican children and adolescents].
    González-Huezo MS; Sánchez-Avila F; García Mayol M; Castro Narro G; Sixtos S; Lisker-Melman M; Kershenobich D
    Rev Gastroenterol Mex; 2003; 68(4):271-6. PubMed ID: 15125329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological priming of one dose of inactivated hepatitis A vaccine given during the first year of life in presence of maternal antibodies.
    Lagos R; Munoz A; Dumas R; Pichon S; Zambrano B; Levine M; Vidor E
    Vaccine; 2003 Sep; 21(25-26):3730-3. PubMed ID: 12922104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decline of maternal hepatitis a antibodies during the first 2 years of life in infants born in Turkey.
    Derya A; Necmi A; Emre A; Akgün Y
    Am J Trop Med Hyg; 2005 Aug; 73(2):457-9. PubMed ID: 16103622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Administration of hepatitis A vaccine at 6 and 12 months of age concomitantly with hexavalent (DTaP-IPV-PRP approximately T-HBs) combination vaccine.
    Stojanov S; Liese JG; Belohradsky BH; Vandermeulen C; Hoppenbrouwers K; Van der Wielen M; Van Damme P; Georges B; Dupuy M; Scemama M; Watson M; Fiquet A; Stek JE; Golm GT; Schödel FP; Kuter BJ;
    Vaccine; 2007 Oct; 25(43):7549-58. PubMed ID: 17905486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis A booster vaccine in children after infant immunization.
    Kanra G; Yalcin SS; Kara A; Ozmert E; Yurdakök K
    Pediatr Infect Dis J; 2002 Aug; 21(8):727-30. PubMed ID: 12192159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Safety and immunogenicity of a new inactivated hepatitis A vaccine].
    Ren A; Ma J; Feng F
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Dec; 15(4):357-9. PubMed ID: 11986726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The study on the 0, 12 month vaccination schedule' of Healive inactivated hepatitis A vaccine in children].
    Ren YH; Chen JT; Wu WT; Gong XJ; Zhang YC; Xue WH; Ren YF; Han LJ; Kang WX; Li SP; Liu CB
    Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Nov; 24(11):1013-5. PubMed ID: 14687502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trial to evaluate immunogenicity and safety of inactivated hepatitis A vaccination starting at 2-month-old children.
    Kanra G; Yalçin SS; Ceyhan M; Yurdakök K
    Turk J Pediatr; 2000; 42(2):105-8. PubMed ID: 10936974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody responses to hepatitis A virus vaccine in HIV-infected children with evidence of immunologic reconstitution while receiving highly active antiretroviral therapy.
    Weinberg A; Gona P; Nachman SA; Defechereux P; Yogev R; Hughes W; Wara D; Spector SA; Read J; Elgie C; Cooper M; Dankner W;
    J Infect Dis; 2006 Jan; 193(2):302-11. PubMed ID: 16362896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.